Bloomberg reports that Germany will soon levy over $2bn worth of price cuts on drug makers launching new products. Germany is the world's third biggest pharma market after the US and Japan, it points out. "The law, backed by the lower house today, gives companies a one-year window to negotiate prices with insurers after introducing … Continue reading Drug price controls growing popular?
Apothecurry 